ArticleOncotarget2017

Correction: Molecular profiling of peripheral blood is associated with circulating tumor cells content and poor survival in metastatic castration-resistant prostate cancer.

Mercedes Marín-Aguilera et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.